ÂÜÀòÂÒÂ×

Michael Fulginiti is an experienced leader in the pharmaceutical industry, currently serving as Director of Global Oncology Training at AstraZeneca since May 2018, where responsibilities include leading US and Global training operations for TAGRISSO, IMFINZI, and IMJUDO in the lung cancer sector, as well as establishing training operations for immuno-oncology products in the GI cancer space. Prior to AstraZeneca, Michael held various director roles at Merck from September 1997 to April 2018, including overseeing the Global Strategic Account Management capability development program and strategic marketing initiatives across the Asia Pacific region. Michael Fulginiti holds an MBA with a concentration in Marketing from Rider University and a Bachelor of Science in Industrial Engineering and Psychology from The College of New Jersey.